Whitney Ijem
Stock Analyst at Canaccord Genuity
(4.66)
# 870
Out of 5,128 analysts
447
Total ratings
43.6%
Success rate
13.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Whitney Ijem
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BEAM Beam Therapeutics | Reiterated: Buy | $78 | $25.81 | +202.21% | 11 | Nov 11, 2026 | |
| GUTS Fractyl Health | Reiterated: Buy | $39 | $0.8812 | +4,325.78% | 20 | Nov 11, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $75 | $36.73 | +104.19% | 2 | Nov 10, 2026 | |
| NGNE Neurogene | Reiterated: Buy | $166 | $25.10 | +561.35% | 8 | Nov 10, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Reiterated: Buy | $20 | $9.31 | +114.82% | 32 | Nov 9, 2026 | |
| NTLA Intellia Therapeutics | Reiterated: Buy | $49 | $11.41 | +329.45% | 24 | Nov 9, 2026 | |
| PVLA Palvella Therapeutics | Reiterated: Buy | $232 → $243 | $163.94 | +48.22% | 23 | Nov 9, 2026 | |
| QNRX Quoin Pharmaceuticals | Reiterated: Buy | $18 | $3.76 | +378.72% | 2 | Nov 9, 2026 | |
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $154 → $168 | $112.16 | +49.79% | 32 | Nov 5, 2026 | |
| OCGN Ocugen | Reiterated: Buy | $11 | $0.9604 | +1,045.36% | 9 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 → $34 | $16.70 | +103.59% | 28 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.3712 | +1,246.98% | 26 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $3.42 | +1,186.55% | 18 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $429 → $323 | $159.85 | +102.06% | 39 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $106 → $108 | $79.54 | +35.78% | 4 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $114 | $58.33 | +95.44% | 25 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $41 | $13.40 | +205.97% | 9 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.48 | +303.23% | 24 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $442 | $547.03 | -19.20% | 40 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $303 | $155.94 | +94.31% | 1 | Sep 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $4.28 | +297.20% | 26 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $4.00 | +475.00% | 15 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $83 → $114 | $308.81 | n/a | 5 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $16.68 | n/a | 2 | Sep 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $169.73 | n/a | 4 | Jan 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $122.27 | n/a | 1 | Jan 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $24.59 | n/a | 4 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $27 | $94.61 | n/a | 2 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 | $0.106 | n/a | 5 | Nov 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $45.75 | n/a | 1 | Oct 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $2.38 | n/a | 1 | Oct 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $21.96 | n/a | 1 | Oct 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.61 | n/a | 2 | Jan 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.19 | n/a | 1 | May 13, 2014 |
Beam Therapeutics
Nov 11, 2026
Reiterated: Buy
Price Target: $78
Current: $25.81
Upside: +202.21%
Fractyl Health
Nov 11, 2026
Reiterated: Buy
Price Target: $39
Current: $0.8812
Upside: +4,325.78%
Maze Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $75
Current: $36.73
Upside: +104.19%
Neurogene
Nov 10, 2026
Reiterated: Buy
Price Target: $166
Current: $25.10
Upside: +561.35%
Arcturus Therapeutics Holdings
Nov 9, 2026
Reiterated: Buy
Price Target: $20
Current: $9.31
Upside: +114.82%
Intellia Therapeutics
Nov 9, 2026
Reiterated: Buy
Price Target: $49
Current: $11.41
Upside: +329.45%
Palvella Therapeutics
Nov 9, 2026
Reiterated: Buy
Price Target: $232 → $243
Current: $163.94
Upside: +48.22%
Quoin Pharmaceuticals
Nov 9, 2026
Reiterated: Buy
Price Target: $18
Current: $3.76
Upside: +378.72%
Rhythm Pharmaceuticals
Nov 5, 2026
Reiterated: Buy
Price Target: $154 → $168
Current: $112.16
Upside: +49.79%
Ocugen
Nov 4, 2026
Reiterated: Buy
Price Target: $11
Current: $0.9604
Upside: +1,045.36%
Nov 4, 2026
Reiterated: Buy
Price Target: $39 → $34
Current: $16.70
Upside: +103.59%
Nov 4, 2026
Reiterated: Buy
Price Target: $5
Current: $0.3712
Upside: +1,246.98%
Nov 4, 2026
Reiterated: Buy
Price Target: $44
Current: $3.42
Upside: +1,186.55%
Nov 2, 2026
Reiterated: Buy
Price Target: $429 → $323
Current: $159.85
Upside: +102.06%
Nov 2, 2026
Reiterated: Buy
Price Target: $106 → $108
Current: $79.54
Upside: +35.78%
Oct 29, 2026
Reiterated: Buy
Price Target: $114
Current: $58.33
Upside: +95.44%
Oct 29, 2026
Reiterated: Buy
Price Target: $38 → $41
Current: $13.40
Upside: +205.97%
Oct 7, 2026
Reiterated: Buy
Price Target: $10
Current: $2.48
Upside: +303.23%
Sep 23, 2026
Reiterated: Hold
Price Target: $442
Current: $547.03
Upside: -19.20%
Sep 4, 2026
Initiated Coverage: Buy
Price Target: $303
Current: $155.94
Upside: +94.31%
Aug 11, 2026
Reiterated: Buy
Price Target: $17
Current: $4.28
Upside: +297.20%
Apr 21, 2026
Reiterated: Buy
Price Target: $23
Current: $4.00
Upside: +475.00%
Feb 28, 2022
Reiterated: Buy
Price Target: $83 → $114
Current: $308.81
Upside: n/a
Sep 15, 2021
Upgraded: Buy
Price Target: n/a
Current: $16.68
Upside: n/a
Jan 4, 2021
Upgraded: Buy
Price Target: n/a
Current: $169.73
Upside: n/a
Jan 4, 2021
Upgraded: Buy
Price Target: n/a
Current: $122.27
Upside: n/a
Jun 25, 2020
Reiterated: Hold
Price Target: n/a
Current: $24.59
Upside: n/a
Dec 16, 2019
Reiterated: Buy
Price Target: $18 → $27
Current: $94.61
Upside: n/a
Nov 9, 2018
Downgraded: Hold
Price Target: $18
Current: $0.106
Upside: n/a
Oct 9, 2018
Initiated Coverage: Hold
Price Target: n/a
Current: $45.75
Upside: n/a
Oct 9, 2018
Initiated Coverage: Hold
Price Target: n/a
Current: $2.38
Upside: n/a
Oct 9, 2018
Initiated Coverage: Buy
Price Target: $35
Current: $21.96
Upside: n/a
Jan 11, 2017
Reiterated: Hold
Price Target: n/a
Current: $1.61
Upside: n/a
May 13, 2014
Reiterated: Hold
Price Target: n/a
Current: $4.19
Upside: n/a